SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor of coronaviruses depends on binding of the viral
spike (S) proteins to cellular receptors and on S protein priming
Molecular Targets in the Chemotherapy of Coronavirus Infection. In the first stage, when the
virus multiplication and accumulation are prevalent under insufficient host immune
Photopolarimetrical properties of coronavirus model particles: Spike proteins number influence the degree of danger of the
virus. A larger number of
spike proteins makes the
virus infectivity stronger
Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current StatusSevere Acute Respiratory Syndrome-Corona
Virus-2 (SARS-CoV-2) induced Coronavirus Disease - 19
Establishment of murine hybridoma cells producing antibodies against spike protein of sars‐cov‐2 mouse mAbs against receptor binding domain of SARS‐CoV‐2
spike (S) protein. These mAbs are able
Study of adsorption of the SARS-CoV-2 virus spike protein by vibrational spectroscopy using terahertz metamaterialsKonnikova, Maria R.,
Cherkasova, Olga P.,
Geints, T. A.,
Dizer, E. S.,
Mankova, A. A.,
Vasilievskii, I. S.,
Butylin, A. A.,
Kistenev, Yury V.,
Tuchin, Valery V.,
Shkurinov, Alexander P. Adhesion of the
spike protein of the SARS-CoV-2
virus is studied by vibrational spectroscopy using